Richard Sykes serves as Executive at Abraxis BioScience, Inc., where they oversee executive responsibilities. Since joining the company, Richard Sykes has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Feb 14, 2020 involved receiving (via award) 384,615 shares valued at $500.0K.
Richard Sykes currently holds 445,108 shares of Abraxis BioScience, Inc. (ABBI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Richard Sykes has been a net neutral trader of ABBI stock. They have purchased $0 and sold $0 worth of shares.
Richard Sykes's most recent insider trade was on Feb 14, 2020, when they sold 384,615 shares at $1.30 per share.
Get notified when new Form 4 filings are submitted
| $20.07 |
| Discretionary |